Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy

Overview of attention for article published in Frontiers in Neurology, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 65 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 67,450 followers.

Serum BDNF as a potential biomarker of Alzheimer's disease: verification through assessment of serum, cerebrospinal fluid, and medial temporal lobe atrophy Yukiko Mori, et al https://t.co/txKRrqwYVX

06 Sep 2024

Reply Repost Favourite

RT @Biosensis: A study using Biosensis' brain derived neurotrophic factor (BDNF) kits shows that there is a significant correlation between…

11 Nov 2021

Reply Repost Favourite

A study using Biosensis' brain derived neurotrophic factor (BDNF) kits shows that there is a significant correlation between serum #BDNF levels and medial temporal lobe atrophy. Serum BDNF levels could thus be a potential biomarker of #Alzheimer's Disease.

07 Nov 2021

Reply Repost Favourite

Brain derived neurotrophic factor(#BDNF) biomarker in #Alzheimers Disease! Researchers use #Biosensis' ELISA (BEK-2211) to compare serum levels to #CSF #tau levels and and state of medial temporal lobe atrophy https://t.co/UXURVsJ2Qf https://t.co/TCqnsl

22 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.